We are pleased to invite you to the fifth annual MyGoals course.
This Multi-disciplinary Gynecologic Oncology Annual Lecture Series was developed in response to the rapidly evolving therapeutic landscape in Gynecologic Oncology.
This one-day program will provide an update on various topics in the field of Gynecologic Oncology. We aim to review advances in surgical management, systemic therapy, radiation therapy and survivorship care for women with gynecologic malignancies. Experts will do the lecture presentations across gynecologic oncology disease sites. Participants will understand the current management options for patients with gynecologic cancers and the options available once patients are referred to cancer centres. This is an inspiring time in gynecologic cancers as many new technologies and targeted therapeutics are emerging. We are thrilled to share these new advances with you at this fifth annual Canadian Royal College accredited educational event.
We look forward to welcoming you on October 21, 2022.
Mansoor Raza Mirza MD
Chief Oncologist, Rigshospitalet
Medical Director, NSGO-CTU (Nordic Society of Gynaecological Oncology - Clinical Trial Unit)
Chairman, ENGOT (European Network of Gynaecological Trial groups)
Executive Director, GCIG (Gynecologic Cancer Inter-Group)
Vice-President, ESGO (European Society of Gynaecological Oncology)
Faculty, ESMO (European Society of Medical Oncology)
Mansoor Raza Mirza, MD is Chief Oncologist at the Department of Oncology, Rigshospitalet - Copenhagen University Hospital, Denmark & Medical Director of Nordic Society of Gynaecological Oncology (NSGO). He is Chair of The European Network of Gynaecological Oncological Trialist Groups (ENGOT). He is the Vice-President of European Society of Gynaecological Oncology (ESGO). He is Executive Director of GCIG, Faculty of European Society of Medical Oncology (ESMO) & European School of Oncology (ESO). He has been study chair of multiple clinical trials in gynecologic cancer for more than three decades. He is author of over 100 publications and invited speaker in most International Congresses. He is member of Board of Directors of Karyopharm Therapeutics Inc., Boston & Sera Prognostics, Salt Lake City, Utah.
- Maintenance PARP inhibitors treatment decisions, controversies, and challenges: Featuring international keynote speaker Dr. Mansoor Raza Mirza
- Biomarkers-driven systemic and radiation therapy in endometrial cancer
- Introduction and integration of the newly developed Ovarian-Adnexal Reporting & Data System (ORADs)
This course is designed to enrich academic and clinical knowledge in gynecologic oncology-related research, clinical management, and survivorship care. The goal of this symposium is to enable health care providers to share and discuss the latest research and clinical applications. All sessions will be presented by experts in the field and will include audience participation.
At the end of this meeting participants will be better able to:
- Understand the debate around PARP in ovarian cancer
- Learn a new approach to endometrial cancer
- Gynecologic Oncologists
- Medical Oncologists
- Radiation Oncologists
- General Gynecologists
- General Practitioner- Oncology
- Oncology Nurses
- Oncology Pharmacists
- Genetic Counsellors
- Physician Assistants
- Trainees in
- Gynecologic Oncology
- Medical Oncology
- Radiation Oncology